A World Health Organization (WHO) official admitted on Saturday that everyone who receives the Monkeypox vaccine is part of a “clinical trial” for the purpose of data collecting to allow researchers to learn more about the vaccines “effectiveness.”
On the same day, the World Health Organization declared the rapidly spreading monkeypox outbreak a ‘global health emergency‘.
WHO Director-General Tedros Adhanom Ghebreyesus personally intervened to overrule the decision of 9 members of an emergency monkeypox committee who had voted against the declaration.
Two sources told Reuters that members of the expert committee were split on the decision, but the responsibility for making the final decision rested with the WHO chief.
Gateway Pundit reports: Tim Nguyen, the Unit Head of Global Infectious Hazards Preparedness at the World Health Organization Emergency Programme, said that the vaccine efficacy is yet unknown since it has never been used on this scale before.
“I would like to underline one thing that is very important to WHO. We do have uncertainty around the effectiveness of these vaccines because they haven’t been used in this context and in this scale before,” Tim Nguyen stressed.
Nguyen warned that anyone who received the Monkeypox vaccination is technically participating in a “clinical trial” to determine the vaccine’s efficacy.
“And therefore, when these vaccines are being delivered, that they are delivered in the context of clinical trial studies and prospectively collecting this data to increase our understanding of the effectiveness of these vaccines,” he said.
Watch the video below:
According to CDC, there are only two vaccines licensed by the U.S. Food and Drug Administration (FDA) available for “preventing monkeypox infection” – JYNNEOS (also known as Imvamune or Imvanex) and ACAM2000.